Scholars Central

Research articlePublished 12 Jun 2017

DOES INTRANASAL STEROIDS REDUCE THE NEED OF ADENOIDECTOMY IN ADENOID HYPERTROPHY

Authors: Sudeep Madisetti, Vineel Muppidi, Lingaiah Jadi, Kalicheti Prabhakar Reddy, Divya Batchu

Journal of Evidence-Based Medicine and Healthcare

Volume 4 · Issue 6 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

BACKGROUND Adenoidal hypertrophy is one of the common pathological condition in the paediatric population. Adenoid hypertrophy manifests as bilateral nasal obstruction, rhinorrhea, cough, snoring, hyponasal speech and sleep apnoea. At present, complications and sequelae of adenoidectomy (i.e., alteration of the immunological system, postoperative bleeding and recurrence of adenoids) are object of criticism. For this reason, research was conducted to test the efficacy of topical nasal steroids in decreasing the severity of nasal symptoms and adenoidal mass. MATERIALS AND METHODS This prospective, controlled study includes 60 children between the ages of 3-12 yrs. who presented with symptoms of adenoid hypertrophy. The study group (33 subjects) underwent course of antibiotic therapy (amoxicillin and potassium clavulanate/cefpodoxime proxetil/cefuroxime axetil) along with mometasone furoate nasal spray 50 mcg in each nostril (100 mcg/day) once daily for 6 weeks, whereas the control group (27 subjects) treated symptomatically with course of antibiotic therapy and saline nasal drops. We assessed the effectiveness of intranasal corticosteroids for improving nasal airway obstruction, thus reducing the need for adenoidectomy. RESULTS We tested the efficacy of Mometasone Furoate (MF) monohydrate to improve the symptom scores of patients with adenoid hypertrophy. 60 children (3-12 years old) were enrolled in a prospective, controlled, clinical study. At the end of the trial, symptom scores improved significantly in the steroid group, while no significant improvements were observed in control patients. CONCLUSION Usage of nasal steroid spray is safe and well tolerated in children. Intranasal steroid therapy can be considered as a treatment option in children with adenoid hypertrophy and in patients who are not willing to undergo or are contraindicated for surgery. In case of failure of intranasal steroidal therapy, adenoidectomy remains the procedure of choice.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Evidence-Based Medicine and Healthcare.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Evidence-Based Medicine and Healthcare
  • SubjectNursing & Healthcare
  • BylineArticles whose byline prints “Sudeep Madisetti”
  • BylineArticles whose byline prints “Vineel Muppidi”
  • BylineArticles whose byline prints “Lingaiah Jadi”
  • BylineArticles whose byline prints “Kalicheti Prabhakar Reddy”
  • BylineArticles whose byline prints “Divya Batchu”